Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?
Background: The presence of actionable alterations in advanced biliary tract cancer patients opened new therapeutic possibilities for second-line treatments. However, for around 60% of the patients, chemotherapy remains the only therapeutic option. The aim of our study was to evaluate outcomes and p...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
MDPI AG
2023-11-01
|
| سلاسل: | Life |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.mdpi.com/2075-1729/13/11/2170 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|